Nimesulid Arena (Nimesulide)

Nimesulide, the active ingredient in Nimesulid Arena, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for systemic use. It is prescribed to relieve pain, reduce inflammation, and lower fever in adult patients with conditions such as osteoarthritis, dysmenorrhea, and acute musculoskeletal discomfort.

GNH USA supplies Nimesulid Arena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Nimesulide is used to manage pain and inflammatory conditions by targeting prostaglandin‑mediated pathways.

- Acute pain: provides rapid analgesia to alleviate discomfort. - Chronic osteoarthritis: reduces joint inflammation and improves mobility. - Dysmenorrhea: lessens menstrual cramps and associated pain. - Fever: lowers elevated body temperature in febrile states. - Inflammatory disorders: diminishes swelling and redness in soft‑tissue inflammation.

Nimesulide may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache. - Dizziness. - Skin rash.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulceration or bleeding.

When prescribing Nimesulide, clinicians should observe several safety measures to minimize risk.

- Assess liver function: obtain baseline hepatic enzymes and monitor periodically. - Avoid in patients with known hypersensitivity to sulfonamides or other NSAIDs. - Use the lowest effective dose for the shortest duration to limit gastrointestinal risk. - Caution in individuals with existing peptic ulcer disease or bleeding disorders. - Monitor renal function: especially in elderly or dehydrated patients. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Nimesulide can interact with several medicines, requiring careful assessment before co‑administration.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, diuretics): possible reduction in antihypertensive effect. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Methotrexate: reduced clearance leading to toxicity.